Clinical trial
Chemotherapy Plus Surgery in Treating Women With Breast Cancer
NCT00003013 · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Other · Completed
Key facts
| NCT number | NCT00003013 |
|---|---|
| Title | Chemotherapy Plus Surgery in Treating Women With Breast Cancer |
| Official title | European Cooperative Study of Chemotherapy and Surgery Comparing Adjuvant Doxorubicin Followed by CMF vs. Adjuvant Doxorubicin/Paclitaxel Followed by CMF vs. Primary Doxorubicin/Paclitaxel Followed by CMF in Women With Operable Breast Cancer and T>2 cm |
| Lead sponsor | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | CMF regimen, cyclophosphamide, doxorubicin hydrochloride, fluorouracil, methotrexate, paclitaxel, tamoxifen citrate, conventional surgery, radiation therapy |
| Enrollment | 450 |
| Start date | Oct 1, 1996 |
| Completion | Mar 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Austria, Czechia, Estonia, Germany, Hungary, Italy, Latvia, Poland, Russia, Slovakia, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: